KEI comments to WHO INB on the Open Source Dividend
Research and Development
Constituency statement for Knowledge Ecology International, Health Action International, Oxfam, and Public Services International: Strengthening WHO preparedness for and response to health emergencies
On 24 May 2022, I delivered the following constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, and Public Services International on the following topic: “16.2 – Strengthening WHO preparedness for and response to health emergencies” at… Continue Reading
White smoke emerges from WHO negotiations on a resolution on Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination
At around 10 PM on Friday evening, 20 May 2022, member states of the World Health Organization (WHO) negotiating on a resolution titled, Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination,… Continue Reading
Additional Comments for the Public Hearing on the Proposed WHO Treaty on Pandemic Preparedness and Response
These are the additional comments to the WHO Public Hearing on a possible WHO treaty or other instrument on pandemic preparedness and response (KEI also provided oral testimony at the hearing, and filed earlier comments here). Luis Gil Abinader –… Continue Reading
KEI comments at WHO public hearing on possible pandemic treaty on preparedness and response
A treaty on pandemic preparedness and response is an opportunity to create a framework that addresses a multitude of issues, including but not limited to these four topics. 1. The treaty should create norms and mechanisms for governments to share… Continue Reading
EB150 – Statement of Knowledge Ecology International (KEI) on Public health emergencies: preparedness and response
On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on a possible pandemic treaty at the 150th session of the World Health Organization’s Executive Board. The WHO negotiations on a pandemic treaty are not a quick… Continue Reading
mRNA
Some companies with mRNA manufacturing capacity Alnylam Pharmaceutics Arcturus Therapeutics Arrowhead Pharmaceuticals BeiGene BioNtech SE CurVac NV Dicerna Pharmaceuticals Genmab Gritstone Bio. Lonza Maravai LifeSciences Holdings Marian Biotech Moderna mRNA RiboTherapeutics, Inc. Pfizer Sanofi Sorrento Therapeutics Tekmira Pharmaceuticals Corporation Translate… Continue Reading
Special Session of the World Health Assembly: Statement of Knowledge Ecology International
On Tuesday, 30 November 2021, Knowledge Ecology International (KEI) delivered the following statement during the special session of the World Health Assembly. Negotiators should address policy failures that have accompanied the current pandemic response, and create a better global framework… Continue Reading
WHO member countries agree on a pathway to draft and negotiate a convention, agreement or other international instrument on pandemic prevention, preparedness and response
After two weeks of intense negotiations, member states of the World Health Organization (WHO) have finally agreed to compromise text on a decision (The World Together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response, SSA2/CONF./1)… Continue Reading
Silence procedure holds for the final report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR)
UPDATE: On Friday, 12 November 2021, the draft report of the Member States Working Group on Strengthening WHO Preparedness for and Response to Health Emergencies (WGPR) was published with the document number, A/WGPR/5/2. The report is available here. The fifth… Continue Reading